BackPressure BioSciences Overview

Pressure BioSciences Accounts Payable

Track Pressure BioSciences's accounts payable ($2.5M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Accounts Payable
$2.49M
↑ 173.35% YoYΔ $1.58M vs prior year quarter

Peer trimmed avg / median

Loading

Pressure BioSciences Accounts Payable History

Loading

Pressure BioSciences vs. peers: Accounts Payable Comparison

Loading

Pressure BioSciences Accounts Payable Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Pressure BioSciences (PBIO) FAQ

As of the most recent data (June 2024), PBIO shows a accounts payable of $2.5M. That compares with $910K in the prior-year period — up 173.4% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, PBIO's accounts payable is now $2.5M (was $910K) — a 173.4% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Pressure BioSciences is outperforming or lagging.

Tracking PBIO's accounts payable over time shows whether Pressure BioSciences is scaling, shrinking, or reshaping that part of the business. The current reading is $2.5M That compares with $910K in the prior-year period — up 173.4% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this accounts payable page, Stockcircle has Pressure BioSciences's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect accounts payable (currently $2.5M) with ownership activity and broader fundamentals.